Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells

被引:80
作者
Getahun, Andrew [1 ,2 ]
Beavers, Nicole A. [1 ,2 ]
Larson, Sandy R. [1 ,2 ]
Shlomchik, Mark J. [3 ]
Cambier, John C. [1 ,2 ]
机构
[1] Univ Colorado, Dept Immunol & Microbiol, Sch Med, Aurora, CO 80045 USA
[2] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA
[3] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15261 USA
基金
美国国家卫生研究院;
关键词
CD4(+) T-CELLS; ACTIVATION MOTIF TYROSINES; FC-GAMMA-RIIB; SELF-TOLERANCE; AUTOANTIBODY PRODUCTION; SOMATIC HYPERMUTATION; NEGATIVE REGULATOR; DISTINCT PATHWAYS; TRANSGENIC MOUSE; MARGINAL ZONE;
D O I
10.1084/jem.20150537
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many autoreactive B cells persist in the periphery in a state of unresponsiveness called anergy. This unresponsiveness is rapidly reversible, requiring continuous BCR interaction with self-antigen and resultant regulatory signaling for its maintenance. Using adoptive transfer of anergic B cells with subsequent acute induction of gene deletion or expression, we demonstrate that the continuous activities of independent inhibitory signaling pathways involving the tyrosine phosphatase SHP-1 and the inositol phosphatase SHIP-1 are required to maintain anergy. Acute breach of anergy by compromise of either of these pathways leads to rapid cell activation, proliferation, and generation of short-lived plasma cells that reside in extrafollicular foci. Results are consistent with predicted/observed reduction in the Lyn-SHIP-1-PTEN-SHP-1 axis function in B cells from systemic lupus erythematosus patients.
引用
收藏
页码:751 / 769
页数:19
相关论文
共 75 条
[1]   SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates [J].
Adachi, T ;
Wienands, J ;
Wakabayashi, C ;
Yakura, H ;
Reth, M ;
Tsubata, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26648-26655
[2]   INDUCTION OF SELF-TOLERANCE IN T-CELLS BUT NOT B-CELLS OF TRANSGENIC MICE EXPRESSING LITTLE SELF ANTIGEN [J].
ADELSTEIN, S ;
PRITCHARDBRISCOE, H ;
ANDERSON, TA ;
CROSBIE, J ;
GAMMON, G ;
LOBLAY, RH ;
BASTEN, A ;
GOODNOW, CC .
SCIENCE, 1991, 251 (4998) :1223-1225
[3]   B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens [J].
Akerlund, Janie ;
Getahun, Andrew ;
Cambier, John C. .
JOURNAL OF AUTOIMMUNITY, 2015, 62 :45-54
[4]   Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function [J].
Anzelon, AN ;
Wu, H ;
Rickert, RC .
NATURE IMMUNOLOGY, 2003, 4 (03) :287-294
[5]   Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive [J].
Benschop, RJ ;
Aviszus, K ;
Zhang, XH ;
Manser, T ;
Cambier, JC ;
Wysocki, LJ .
IMMUNITY, 2001, 14 (01) :33-43
[6]   Suppression of Phosphatidylinositol 3,4,5-Trisphosphate Production Is a Key Determinant of B Cell Anergy [J].
Browne, Cecille D. ;
Del Nagro, Christopher J. ;
Cato, Matthew H. ;
Dengler, Hart S. ;
Rickert, Robert C. .
IMMUNITY, 2009, 31 (05) :749-760
[7]   Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways [J].
Cambier, John C. .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (05) :1928-1931
[8]   B cell receptor signal strength determines B cell fate [J].
Casola, S ;
Otipoby, KL ;
Alimzhanov, M ;
Humme, S ;
Uyttersprot, N ;
Kutok, JL ;
Carroll, MC ;
Rajewsky, K .
NATURE IMMUNOLOGY, 2004, 5 (03) :317-327
[9]   The Inositol Phosphatase SHIP-1 Inhibits NOD2-Induced NF-κB Activation by Disturbing the Interaction of XIAP with RIP2 [J].
Conde, Claude ;
Rambout, Xavier ;
Lebrun, Marielle ;
Lecat, Aurore ;
Di Valentin, Emmanuel ;
Dequiedt, Franck ;
Piette, Jacques ;
Gloire, Geoffrey ;
Legrand, Sylvie .
PLOS ONE, 2012, 7 (07)
[10]   Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection [J].
Cornall, RJ ;
Cyster, JG ;
Hibbs, ML ;
Dunn, AR ;
Otipoby, KL ;
Clark, EA ;
Goodnow, CC .
IMMUNITY, 1998, 8 (04) :497-508